Skip to Content

Tag: Diabetes


Also Noted

Medtronic sensor receives FDA clearance

April 22, 2025HME News Staff

GALWAY, Ireland – Medtronic has received clearance from the U.S. Food and Drug Administration for the Simplera Sync sensor for use with the MiniMed 780G system. With this approval, the MiniMed 780G system now offers more flexibility for users of the company's most advanced insulin delivery system featuring Meal Detection technology with both the Guardian 4 sensor and Simplera Sync sensor. The Simplera Sync is a disposable, all-in-one sensor that requires no fingersticks with SmartGuard...

Diabetes, Insulin pump, Medtronic


Read Full Articlered right arrow icon

Mahmood Kazemi

Specialty Providers

Abbott seeks to go ‘above the bias’

March 28, 2025Theresa Flaherty, Managing Editor

ALAMEDA, Calif. – Nearly 70% of people with diabetes believe there is stigma associated with their condition, according to a survey from Abbott, and that can stand in the way of care, says Dr. Mahmood Kazemi.   “Misconceptions and stereotypes about diabetes can prevent some people from getting care,” said Kazemi, divisional vice president, medical/clinical affairs and chief medical officer, Abbott Diabetes Care. “It’s disheartening. What is promising, though,...

Abbott Diabetes Care, Diabetes, Dr. Mahmood Kazemi


Read Full Articlered right arrow icon

Also Noted

FDA issues warning to Dexcom

March 27, 2025HME News Staff

SAN DIEGO – Dexcom has received a warning letter from the U.S. Food and Drug Administration regarding “non-conformities” in manufacturing and quality processes after inspections of its facilities in Sad Diego and Mesa, Ariz. In a form 8-K filed with the U.S. Securities and Exchange Commission, the company said it takes the matters identified in the warning letter seriously, has already submitted several responses to Form 483 and is in the process of preparing a written response...

Continuous Glucose Monitor (CGM), Dexcom, Diabetes, Food & Drug Administration (FDA)


Read Full Articlered right arrow icon

Arti Masturzo

Specialty Providers

DMEs improve adherence, lower costs & reduce utilization, study finds 

March 25, 2025HME News Staff

DALLAS – There are significant advantages for patients receiving continuous glucose monitors through DME providers compared to pharmacies, including higher adherence rates, according to a new study published in Clinical Diabetes, a peer-reviewed journal of the American Diabetes Association.  The study, supported by CCS, demonstrates that efforts to expand access to CGMs by adding pharmacy as a new channel for distribution — alongside the established DME provider channel —...

Adherence, CCS, Continuous Glucose Monitor (CGM), CPAP Therapy, Diabetes


Read Full Articlered right arrow icon

Specialty Providers

‘Now is the time to push for greater investment in CGM tech,’ report finds 

March 24, 2025HME News Staff

EDINBURGH, Scotland, and SAN DIEGO – Tech, not medicine, is the future of care for Type 2 diabetes patients, according to a new report from Dexcom.  Fifty-two percent of health care professionals ranked access to continuous glucose monitors and education as having the potential to positively help people with Type 2 manage their condition in the next 10 years compared with 30% who cited better or more effective medications.  “With policymakers increasingly focused on digital...

Continuous Glucose Monitor (CGM), Dexcom, Diabetes


Read Full Articlered right arrow icon

Arti Masturzo

Specialty Providers

DME providers can help physicians manage diabetes population, study finds

March 21, 2025Theresa Flaherty, Managing Editor

DALLAS – The No. 1 reason physicians cite for not prescribing a continuous glucose monitor is its complexity, a roadblock that DME providers can help clear, according to a new study from CCS.  That complexity, along with a surge in the number of diabetes patients, leaves primary care physicians and endocrinologists feeling overwhelmed and not able to keep up-to-date on technology, and, ultimately, struggling to offer enough health coaching and education to their patients. That creates...

Arti Masturzo, CCS, Continuous Glucose Monitor (CGM), Diabetes


Read Full Articlered right arrow icon

Also Noted

Sequel Med Tech collaborates with Abbott 

March 19, 2025HME News Staff

MANCHESTER, N.H. – Sequel Med Tech has announced that Abbott’s FreeStyle Libre 3 Plus sensor will be the first continuous glucose monitoring device to work with its twiist Automated Insulin Delivery (AID) System powered by Tidepool. The sensor will be compatible with twiist when the system is expected to launch in the second quarter of 2025. “We are thrilled to announce our collaboration with Abbott, integrating its world-leading FreeStyle Libre technology as our first CGM partner,...

Abbott, Continuous Glucose Monitor (CGM), Diabetes, FreeStyle Libre 3, Sequel Med Tech, twiist


Read Full Articlered right arrow icon

Providers

Strive Medical builds out diabetes biz

March 5, 2025HME News Staff

IRVING, Texas – Strive Medical, a portfolio company of NMS Capital, has acquired Charles Pharmacy & Surgical, a pharmacy and provider of diabetes supplies since 1968.  This strategic acquisition represents a major milestone in Strive Medical's continuous growth and dedication to delivering top-quality medical supplies and services to patients throughout the United States, the company says.  "We are thrilled to welcome Charles Pharmacy into the Strive Medical community,"...

Charles Pharmacy & Surgical, Diabetes, Paragon Ventures, Strive Medical


Read Full Articlered right arrow icon

News

In brief: Owens & Minor explores P&HS sale, Grassley challenges UHC, CCS details burnout

February 28, 2025HME News Staff

RICHMOND, Va.– Owens & Minor is looking to sell off its Products & Healthcare Services business, while it remains “bullish” on its Patient Direct business.  The company made the announcement today, as part of its fourth quarter and full-year 2024 earnings results.  “Our commitment to directing capital toward the higher growth and higher margin Patient Direct segment has been increasingly evident in recent years and is consistent with our strategy,” said...

ACU-Serve, CCS, Chuck Grassley, Diabetes, Medicare Advantage, Owens & Minor, ResMed, Rotech Healthcare, Sleep, UnitedHealth Group


Read Full Articlered right arrow icon

Suzanne Foster

Providers

AdaptHealth: Diabetes course correct shows ‘promising signs’ 

February 26, 2025Theresa Flaherty, Managing Editor

PLYMOUTH MEETING, Pa. – After consecutive declining quarters in Diabetes Health, AdaptHealth has remodeled its diabetes outreach program and integrated diabetes resupply into sleep resupply and adopted that segment's best practices, says CEO Suzanne Foster.  A diagnostic review highlighted several reasons for Diabetes Health’s underperformance, she told analysts on a recent call to discuss the company’s fourth quarter and full year 2024 financial results.  “Notwithstanding...

2024, AdaptHealth, Diabetes, Financial Results, fourth quarter, full year


Read Full Articlered right arrow icon